Upperton Advances Sterile Manufacturing Facility with MHRA Submission
Upperton advances sterile manufacturing facility following MHRA submission.
PR
How Upperton Has Evolved to Meet the Changing Needs of Biotechs
What exactly is the difference between a CDMO, a CRO, and a CMO? Each plays a vital role in the life sciences ecosystem.
What Biotech Startups Need to Know About Sterile Fill-Finish Services
What exactly is the difference between a CDMO, a CRO, and a CMO? Each plays a vital role in the life sciences ecosystem.
Low Bioburden Powders for Terminal Sterilisation: Raising the Standard in Modern Drug Development
The pressure of speed to clinic is continuing to increase. Biotechs are under more pressure, and therefore the CDMOs supporting them must evolve too
DDL 2025 – The Next Chapter in Inhalation
• The pressure of speed to clinic is continuing to increase. Biotechs are under more pressure, and therefore the CDMOs supporting them must evolve too
Business Development Spotlight with Christopher Bjerkan Wade
Discover more about our team. In this Spotlight, meet our Senior Business Development Director, Christopher Bjerkan Wade.
The Evolution of Biotech and CDMO Partnerships
• The pressure of speed to clinic is continuing to increase. Biotechs are under more pressure, and therefore the CDMOs supporting them must evolve too
Developments in OSD Manufacturing: What Biotechs Need to Know
What do biotechs need to know about oral solid dose manufacturing? Learn about how partnering with a CDMO can provide a competitive edge
What’s Next in Pharmaceutical R&D? A Conversation with Upperton’s Director of Pharmaceutical Sciences
We speak to Upperton’s Director of Pharmaceutical Sciences, Laura Mason, about the upcoming trends she sees emerging in the R&D lab.
Does a One-Site CDMO Make a Difference in Drug Development?
A one-site CDMO is where GMP, R&D and manufacturing all operate on one site, making the movement of projects streamlined.